Drug
DiaPep 277 clinical trials
Also written DiaPep277.
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
7 studies that test it; most in 2002 (1)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 2
Andromeda Biotech Ltd. (4) · Rabin Medical Center (1) · DeveloGen Israel, Ltd. (1) · Hadassah Medical Organization (1)
Studies
Open first, then newest update. How each study uses DiaPep 277 is read from its arms, and is right about nine times in ten.
Testing it · 7
- The Safety and Efficacy of Administrating DiaPep277® Vaccination in Type 1 Diabetes Patients.WithdrawnPhase 1/2Hadassah Medical OrganizationNCT01881958Written as DiaPep277®
- Efficacy Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes PatientsCompletedPhase 3Andromeda Biotech Ltd.NCT00615264Written as DiaPep277
- Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes AdultsCompletedPhase 3Andromeda Biotech Ltd.NCT01103284Written as DiaPep277
- Open-Label Extension Study to Evaluate Long Term Safety and Treatment Effect of DiaPep277®TerminatedPhase 3Andromeda Biotech Ltd.NCT01898286Written as DiaPep277®
- OPen Label Study to Evaluate Long Term Treatment Effect of DiaPep277TerminatedPhase 3Rabin Medical CenterNCT01460251Written as DiaPep277
- Long-Term Treatment Effect of DiaPep277 in Type 1 DiabetesCompletedPhase 3Andromeda Biotech Ltd.NCT00644501Written as DiaPep277
- Safety, Tolerability, Immunological and Clinical Efficacy of Multiple Subcutaneous Doses of DiaPep277 in Latent Autoimmune Diabetes in Adults (LADA)TerminatedPhase 2DeveloGen Israel, Ltd.NCT00058981Written as DiaPep277